• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例经股新型自膨式经导管心脏瓣膜植入术治疗单纯主动脉瓣反流。

First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation.

机构信息

University Heart Center, Hamburg, Hamburg, Germany.

出版信息

EuroIntervention. 2017 Dec 20;13(11):1296-1299. doi: 10.4244/EIJ-D-17-00502.

DOI:10.4244/EIJ-D-17-00502
PMID:28846544
Abstract

Here we will describe the first case of a novel JenaValve design (JenaValve Technology, Irvine, CA, USA) using the transfemoral approach in a 78-year-old female patient with pure aortic regurgitation. The implantation was successfully performed with good haemodynamics and good clinical outcome at six-month follow- up. The technology is especially appealing in non-calcified anatomies due to the clipping mechanism which was previously utilised in the transapical design.

摘要

在此,我们将描述首例使用经股动脉入路的新型 JenaValve 设计(JenaValve Technology,美国加利福尼亚州欧文市)的病例,该设计用于治疗一名 78 岁女性单纯主动脉瓣反流患者。该植入术在血流动力学方面表现良好,且在 6 个月的随访中取得了良好的临床效果。该技术特别适用于非钙化解剖结构,因为其夹合机制此前已应用于经心尖设计。

相似文献

1
First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation.首例经股新型自膨式经导管心脏瓣膜植入术治疗单纯主动脉瓣反流。
EuroIntervention. 2017 Dec 20;13(11):1296-1299. doi: 10.4244/EIJ-D-17-00502.
2
Transfemoral transcatheter aortic valve implantation for treatment of severe aortic regurgitation in a patient with previous aortic valve-sparing operation according to David.经股动脉经导管主动脉瓣植入术治疗1例曾根据David术式行保留主动脉瓣手术患者的严重主动脉瓣反流
Cardiovasc Revasc Med. 2017 Dec;18(8):611-615. doi: 10.1016/j.carrev.2017.06.010. Epub 2017 Jul 5.
3
Rescue Valve-in-Valve Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation.经导管主动脉瓣置换术中的挽救性瓣中瓣技术治疗单纯主动脉瓣反流
JACC Cardiovasc Interv. 2017 Feb 13;10(3):e23-e24. doi: 10.1016/j.jcin.2016.11.031. Epub 2017 Jan 18.
4
Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve.经心尖经导管主动脉瓣置换术治疗第二代心脏瓣膜的主动脉瓣反流。
J Thorac Cardiovasc Surg. 2018 Jul;156(1):106-116. doi: 10.1016/j.jtcvs.2017.12.150. Epub 2018 Feb 13.
5
A novel, transfemoral prosthesis designed to treat aortic valve regurgitation: technical aspects and procedural guide.
J Cardiovasc Med (Hagerstown). 2019 Dec;20(12):844-848. doi: 10.2459/JCM.0000000000000874.
6
Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.德国初步经验:经心尖植入第二代经导管心脏瓣膜治疗主动脉瓣反流。
JACC Cardiovasc Interv. 2014 Oct;7(10):1168-74. doi: 10.1016/j.jcin.2014.05.014. Epub 2014 Aug 13.
7
Transfemoral transcatheter aortic valve replacement in the presence of a mitral prosthesis.股动脉入路行经导管主动脉瓣置换术同期二尖瓣假体置换。
J Cardiovasc Med (Hagerstown). 2019 Dec;20(12):825-830. doi: 10.2459/JCM.0000000000000876.
8
Successful Transcatheter Aortic Valve Replacement for Severe Aortic Valve Regurgitation Following a David I Valve-Sparing Procedure.大卫I型保留瓣膜手术后继发严重主动脉瓣反流的成功经导管主动脉瓣置换术
JACC Cardiovasc Interv. 2017 Jun 12;10(11):e101-e103. doi: 10.1016/j.jcin.2017.03.035. Epub 2017 May 17.
9
The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.JUPITER注册研究:使用第二代经导管心脏瓣膜经心尖主动脉瓣植入治疗主动脉瓣关闭不全的一年结局
Catheter Cardiovasc Interv. 2018 Jun;91(7):1345-1351. doi: 10.1002/ccd.27370. Epub 2017 Nov 24.
10
Transapical transcatheter aortic valve replacement with a novel transcatheter aortic valve replacement system in high-risk patients with severe aortic valve diseases.经心尖入路应用新型经导管主动脉瓣置换系统治疗高危重度主动脉瓣疾病患者
J Thorac Cardiovasc Surg. 2018 Feb;155(2):588-597. doi: 10.1016/j.jtcvs.2017.09.015. Epub 2017 Sep 15.

引用本文的文献

1
Epidemiology of Valvular Heart Disease in Asia Pacific Region.亚太地区心脏瓣膜病流行病学
JACC Asia. 2025 May 3;5(6):718-43. doi: 10.1016/j.jacasi.2025.03.011.
2
Transcatheter Aortic Valve Replacement in Patients With Quadricuspid Aortic Valve: A Case Series and Systematic Review.四叶式主动脉瓣患者的经导管主动脉瓣置换术:病例系列与系统评价
Cardiol Res Pract. 2025 Feb 5;2025:7815279. doi: 10.1155/crp/7815279. eCollection 2025.
3
Contemporary Management of the Aortic Valve-Narrative Review of an Evolving Landscape.主动脉瓣的当代管理——对不断演变格局的叙述性综述
J Clin Med. 2024 Dec 29;14(1):134. doi: 10.3390/jcm14010134.
4
Aortic regurgitation: from mechanisms to management.主动脉瓣反流:从机制到治疗。
EuroIntervention. 2024 Sep 2;20(17):e1062-e1075. doi: 10.4244/EIJ-D-23-00840.
5
Cerebral ischemic injury after transcatheter aortic valve replacement in patients with pure aortic regurgitation.单纯主动脉瓣反流患者经导管主动脉瓣置换术后的脑缺血性损伤。
J Zhejiang Univ Sci B. 2023 Jun 15;24(6):530-538. doi: 10.1631/jzus.B2200444.
6
What's New with TAVR? An Update on Device Technology.经导管主动脉瓣置换术(TAVR)有哪些新进展?器械技术更新。
Methodist Debakey Cardiovasc J. 2023 May 16;19(3):4-14. doi: 10.14797/mdcvj.1230. eCollection 2023.
7
Transcatheter Aortic Valve Implantation for Pure Native Aortic Regurgitation: The Last Frontier.经导管主动脉瓣植入术治疗单纯原发性主动脉瓣反流:最后的前沿领域。
J Clin Med. 2022 Sep 1;11(17):5181. doi: 10.3390/jcm11175181.
8
Transcatheter Aortic Valve Implantation for Severe Pure Aortic Regurgitation With Dedicated Devices.使用专用器械经导管主动脉瓣植入治疗重度单纯主动脉瓣反流
Interv Cardiol. 2022 Jul 21;17:e11. doi: 10.15420/icr.2021.19. eCollection 2022 Jan.
9
Application of three-dimensional transesophageal echocardiography in preoperative evaluation of transcatheter aortic valve replacement.三维经食管超声心动图在经导管主动脉瓣置换术术前评估中的应用。
BMC Cardiovasc Disord. 2021 Jun 28;21(1):315. doi: 10.1186/s12872-021-02101-7.
10
TAVI for Pure Native Aortic Regurgitation: Are We There Yet?经导管主动脉瓣植入术治疗单纯原发性主动脉瓣反流:我们做到了吗?
Interv Cardiol. 2019 Feb;14(1):26-30. doi: 10.15420/icr.2018.37.1.